Evidence map›Paper›PMID 28427205›Full record

ArticleOncotarget2017

MNS16A tandem repeat minisatellite of human telomerase gene: functional studies in colorectal, lung and prostate cancer.

Philipp Hofer, Cornelia Zöchmeister, Christian Behm, Stefanie Brezina, Andreas Baierl, Angelina Doriguzzi, Vanita Vanas, Klaus Holzmann, Hedwig Sutterlüty-Fall, Andrea Gsur

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Association of hTERT MNS16A polymorphism with clinical outcomes of North Indian lung cancer patients undergoing platinum-based doublet chemotherapy.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Article
  2. Article
  3. Article
  4. Relationship between Telomere Length,International journal of molecular sciences · 2022
    Article
  5. Article
  6. Article
  7. Variability within the humanOncoTargets and therapy · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Philipp HoferMedical University of Vienna, Institute of Cancer Research, A-1090 Vienna, Austria.
Cornelia ZöchmeisterMedical University of Vienna, Institute of Cancer Research, A-1090 Vienna, Austria.
Christian BehmMedical University of Vienna, Institute of Cancer Research, A-1090 Vienna, Austria.
Stefanie BrezinaMedical University of Vienna, Institute of Cancer Research, A-1090 Vienna, Austria.
Andreas BaierlUniversity of Vienna, Department of Statistics and Operations Research, A-1010 Vienna, Austria.
Angelina DoriguzziMedical University of Vienna, Institute of Cancer Research, A-1090 Vienna, Austria.
Vanita VanasMedical University of Vienna, Institute of Cancer Research, A-1090 Vienna, Austria.
Klaus HolzmannMedical University of Vienna, Institute of Cancer Research, A-1090 Vienna, Austria.
Hedwig Sutterlüty-FallMedical University of Vienna, Institute of Cancer Research, A-1090 Vienna, Austria.
Andrea GsurMedical University of Vienna, Institute of Cancer Research, A-1090 Vienna, Austria.
Medical University of Vienna · ATUniversity of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MNS16A, a functional polymorphic tandem repeat minisatellite, is located in the promoter region of an antisense transcript of the human telomerase reverse transcriptase gene. MNS16A promoter activity depends on the variable number of tandem repeats (VNTR) presenting varying numbers of transcription factor binding sites for GATA binding protein 1. Although MNS16A has been investigated in multiple cancer epidemiology studies with incongruent findings, functional data of only two VNTRs (VNTR-243 and VNTR-302) were available thus far, linking the shorter VNTR to higher promoter activity.For the first time, we investigated promoter activity of all six VNTRs of MNS16A in cell lines of colorectal, lung and prostate cancer using Luciferase reporter assay. In all investigated cell lines shorter VNTRs showed higher promoter activity. While this anticipated indirect linear relationship was affirmed for colorectal cancer SW480 (P = 0.006), a piecewise linear regression model provided significantly better model fit in lung cancer A-427 (P = 6.9 × 10-9) and prostate cancer LNCaP (P = 0.039). In silico search for transcription factor binding sites in MNS16A core repeat element suggested a higher degree of complexity involving X-box binding protein 1, general transcription factor II-I, and glucocorticoid receptor alpha in addition to GATA binding protein 1.Further functional studies in additional cancers are requested to extend our knowledge of MNS16A functionality uncovering potential cancer type-specific differences. Risk alleles may vary in different malignancies and their determination in vitro could be relevant for interpretation of genotype data.

Indexed as

Minisatellite RepeatsBinding SitesCell Line, TumorColorectal NeoplasmsFemaleGene Expression Regulation, NeoplasticGenetic VariationHumansLung NeoplasmsMalePolymorphism, GeneticPromoter Regions, GeneticProstatic NeoplasmsProtein BindingTelomeraseTranscription FactorsTelomeraseTERT protein, humanTranscription Factorsfunctional polymorphismgenetic variationMNS16AtelomeraseTERT regulation

Identifiers

PMID28427205
PMCPMC5438627
OpenAlexW2591962782

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.